Join ADLM
ADLM professional members save $125 on ADLM 2026. Join for just $275 a year and enjoy year-round benefits.
Course ID: 191206
3.0 ACCENT credits /3.0 CME credits
Sunday, July 26, 2026
Afternoon course | 1 p.m. – 4 p.m. US Pacific Time
Anaheim Marriott (next to Anaheim Convention Center)
Laboratories must increasingly move beyond analytic accuracy to demonstrate value within the broader health system. Determining the downstream impact of laboratory testing, as measured through metrics such as decreased length of stay or improved patient outcomes, is critical to this process but remains a complex challenge. Real-world data, including electronic health records, provide an important opportunity for quantifying diagnostic utility. This course will showcase advanced analytic methods and real-world studies that use causal inference modeling with large data sources to rigorously assess the consequences, both intended and unintended, of diagnostic strategies. This interactive workshop will convene laboratorians, clinicians, and informaticists for an immersive experience using synthetic and de-identified EHR datasets. Participants will explore key health system performance indicators that contribute to defining value in contemporary healthcare and gain practical skills in causal inference techniques, including directed acyclic graphs (DAGs), target trial emulation, and propensity score methods.
Lab directors (and/or assistant directors); Lab managers (supervisory and/or non-supervisory); Physicians; Pathologists
Intermediate
After participating in this course, participants will be able to:
Dr. Schroeder will open the course by outlining the agenda and reviewing logistical details. This introductory segment will frame the importance of focusing on diagnostic value and set expectations for the interactive and hands-on nature of the course.
Dr. Schroeder will introduce key concepts related to diagnostic value and utility, including how diagnostic testing contributes to patient outcomes and health system performance. The session will address strategies for selecting appropriate outcomes to target when assessing diagnostic value. Participants will then engage in a hands-on group exercise to evaluate a set of value-based diagnostic targets and discuss their relevance and feasibility.
Dr. Admon will introduce core causal inference methods for evaluating diagnostic utility, comparing randomized trials with real-world evidence approaches. Participants will explore tools like Directed acyclic graphs (DAGs), target trial emulation, and propensity scores, discuss study design strategies, and work collaboratively to build and interpret a diagnostic strategy DAG for a selected project.
Dr. O’Connell will review key data sources for comparative diagnostic studies, including EHR platforms, institutional warehouses, standardized data models, and centralized databases. Participants will examine strengths, limitations, and practical considerations, and engage in discussion on selecting the right data source for specific diagnostic questions.
Drs. O’Connell and Schroeder will guide participants through identifying cohorts and outcomes in EHR systems, including Epic Clarity. The session will address common data challenges and feature a live demonstration on preparing datasets for diagnostic strategy comparisons.
Faculty will lead a hands-on session on assessing diagnostic utility, covering propensity scores, analytic comparisons in R, and calculation of diagnostic performance measures. Participants will complete a guided analysis using sample datasets and code.
This section will focus on interpreting analytic results and translating findings into practice. Faculty will discuss strategies for communicating results to both clinical and administrative audiences and for moving from analysis to meaningful practice change.